VBL Therapeutics Enters Into Ordinary Share Purchase Agreement of up to $20 Million With Aspire Capital Fund, LLC

    NEXT STORY
    Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
    PREV STORY
    TG Therapeutics to Participate in the B. Riley Securities Oncology Investor Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    NAESP’s Statement of Support for Passage of the FY18 Omnibus Appropriations Bill

    Alexandria, Va., March 23, 2018 (GLOBE NEWSWIRE) -- The National Association of Elementary School ...

    author_avatar
    NASDAQ Market News

    Mateon Therapeutics to Present New Improved Survival Outcomes for CA4P in Recurrent Ovarian Cancer at June 27 Investor Event

    Updated data shows improvement in overall survival of 3.2 months for all CA4P-treated patients ...

    author_avatar
    NASDAQ Market News

    More Than 20 Cerner Executives Earn Board Certification in Health Care Management

    KANSAS CITY, Mo., March 30, 2018 (GLOBE NEWSWIRE) -- Cerner announced that 21 of ...

    author_avatar
    NASDAQ Market News